Simple question to ask for reducing anyone hate or hype down to the lowest common denominator, has your share grown??? Has breo grown enough to combat generic advair? Has Tanzuem grown to be a regular player? Is anoro taking its rightful position? Does incruise have a strong foothold yet? Answer honest, the sinking ship has a hole and if most answer no then perhaps it's time to find a new boat. Look for jobs now.
A chimp with samples could support Advair at this point.......it's been around for 10+ years and has great formulary coverage. #youdidntbuildthat
only Incruse is making the numbers, and that's mostly thanks due to Managed Care changes. Doubling the SOV for Anoro is another astounding clueless attempt to protect temporary management positions. #idiotsallofthem
It's not really doubling the share of voice, since CVMU is already aligned to Anoro. It's forcing CVMU to actually give a shit about it, so they will maybe try harder. Won't be difficult for CVMU to creat impact....they have already made a difference, unlike what respiratory reps were doing with it.